6CPA Mental Health Pharmacy Trial: The Pharmacy Guild of Australia, the Pharmaceutical Society of Australia, Griffith University and the University of Sydney have announced that the Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge) trial will commence next month.
This study focuses on individualised medicine support, adherence and mental and physical wellbeing for people living with severe and persistent mental illness. This project is an important initiative to broaden the role of pharmacists in helping people living with mental illness.
Pharmacists serve as a critical element in the healthcare team, working with patients to manage their conditions, often as a conduit to other services, an advocate for the person, or to lend a compassionate ear.
The trial will be conducted in four study regions: Hunter New England and Northern Sydney regions in NSW, Gippsland region in Victoria, and ACT.
Participating community pharmacies will be remunerated to support training attendance and to deliver either the PharMIbridge (intervention) or study funded MedsCheck (comparator) service.
If you would like further information, please email pharmibridge@griffith.edu.au or visit griffith.edu.au/pharmibridge.
This project is part of the Pharmacy Trial Program funded under the 6CPA.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 20
